<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034513488787</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034513488787</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Biological</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of Allergen Sensitization on External Root Resorption</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Murata</surname><given-names>N.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
<xref ref-type="aff" rid="aff2-0022034513488787">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ioi</surname><given-names>H.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034513488787">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ouchi</surname><given-names>M.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
<xref ref-type="aff" rid="aff2-0022034513488787">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Takao</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Oida</surname><given-names>H.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Aijima</surname><given-names>R.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yamaza</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kido</surname><given-names>M.A.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034513488787">1</xref>
<xref ref-type="corresp" rid="corresp1-0022034513488787">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034513488787"><label>1</label>Department of Molecular Cell Biology and Oral Anatomy, Graduate School of Dental Science, Kyushu University, Fukuoka 812-8582, Japan</aff>
<aff id="aff2-0022034513488787"><label>2</label>Department of Orthodontics, Graduate School of Dental Science, Kyushu University, Fukuoka, Japan</aff>
<author-notes>
<corresp id="corresp1-0022034513488787"><label>*</label><email>kido@dent.kyushu-u.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>92</volume>
<issue>7</issue>
<fpage>641</fpage>
<lpage>647</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>3</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>4</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>In orthodontic tooth movement (OTM), we should be concerned about external root resorption (ERR) as an undesirable iatrogenic problem, but its mechanisms are not fully understood. Since our previous epidemiologic studies found that patients with allergic diseases showed higher rates of ERR during orthodontic treatment, we explored the possible effect of allergic sensitization on ERR. In ovalbumin (OVA)-sensitized Brown–Norway rats, the amounts of ERR and OTM were greater than those in animals subjected to orthodontic force alone. The expression levels of RANKL and pro-inflammatory cytokines were increased in the periodontal tissues of sensitized rats with OTM, compared with control rats. Furthermore, leukotriene B<sub>4</sub> (LTB<sub>4</sub>), a potent lipid mediator of allergic inflammation, and enzymes of the 5-lipoxygenase pathway, the biosynthetic pathway of leukotrienes, were also up-regulated. We found that low doses of aspirin suppressed ERR in allergen-sensitized rats, as well as the expressions of RANKL, pro-inflammatory cytokines, and LTB<sub>4</sub>. The present findings indicate that allergen sensitization has adverse effects on ERR under OTM, and that aspirin is a potential therapeutic agent for combating ERR.</p>
</abstract>
<kwd-group>
<kwd>allergy</kwd>
<kwd>tooth movement</kwd>
<kwd>cytokines</kwd>
<kwd>leukotrienes</kwd>
<kwd>aspirin</kwd>
<kwd>rats</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034513488787" sec-type="intro">
<title>Introduction</title>
<p>Many orthodontists consider that undesirable external root resorption (ERR) is an unavoidable and unpredictable pathologic consequence of orthodontic tooth movement (OTM). Serious cases may involve shortening of the tooth roots, which in turn shortens the life of the tooth. This problem remains a matter of grave concern for orthodontic treatments. A few clinical reviews concerning ERR have suggested the involvement of systemic conditions, including allergic conditions (<xref ref-type="bibr" rid="bibr21-0022034513488787">McNab <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="bibr7-0022034513488787">Davidovitch <italic>et al</italic>., 2000</xref>). Indeed, we previously showed that Japanese patients with allergic diseases had higher rates of orthodontically induced root resorption (<xref ref-type="bibr" rid="bibr23-0022034513488787">Nishioka <italic>et al</italic>., 2006</xref>). However, the mechanisms of ERR under allergic conditions are still poorly understood.</p>
<p>Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β, and receptor activator of nuclear factor κB ligand (RANKL) play well-known roles in bone resorption through the induction of osteoclast differentiation (<xref ref-type="bibr" rid="bibr12-0022034513488787">Heath <italic>et al</italic>., 1985</xref>; <xref ref-type="bibr" rid="bibr5-0022034513488787">Bertolini <italic>et al</italic>., 1986</xref>), and have been suggested to be involved in OTM (<xref ref-type="bibr" rid="bibr19-0022034513488787">Lowney <italic>et al</italic>., 1995</xref>; <xref ref-type="bibr" rid="bibr15-0022034513488787">Kanzaki <italic>et al</italic>., 2002</xref>). TNF-α and IL-1β induce local expression of RANKL, which is critical for the terminal differentiation of osteoclast precursor cells (<xref ref-type="bibr" rid="bibr26-0022034513488787">Suda <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="bibr1-0022034513488787">Azuma <italic>et al</italic>., 2000</xref>). Furthermore, leukotrienes, which are metabolites of arachidonic acid, are potent lipid mediators that play important roles in allergic inflammation and constitute several products of the 5-lipoxygenase (5-LOX) pathway (<xref ref-type="bibr" rid="bibr22-0022034513488787">Murphy and Gijon, 2007</xref>). Increased levels of leukotrienes are found in inflammatory diseases such as asthma and periodontal diseases (<xref ref-type="bibr" rid="bibr8-0022034513488787">Emingil <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr11-0022034513488787">Hallstrand and Henderson, 2010</xref>). <xref ref-type="bibr" rid="bibr13-0022034513488787">Hikiji <italic>et al</italic>. (2009)</xref> reported that leukotriene B<sub>4</sub> (LTB<sub>4</sub>) modulates bone metabolism by increasing bone resorption. These LTB<sub>4</sub> actions are mediated by specific receptors, BLT1 and BLT2 (<xref ref-type="bibr" rid="bibr29-0022034513488787">Yokomizo <italic>et al</italic>., 1997</xref>, <xref ref-type="bibr" rid="bibr30-0022034513488787">2000</xref>).</p>
<p>Brown–Norway (BN) rats, which spontaneously produce high levels of serum IgE and show further highly enhanced serum IgE levels after sensitization with ovalbumin (OVA), have been extensively used as animal models of asthma (<xref ref-type="bibr" rid="bibr3-0022034513488787">Bellofiore and Martin, 1988</xref>) and atopic dermatitis (<xref ref-type="bibr" rid="bibr14-0022034513488787">Imada <italic>et al</italic>., 2002</xref>).</p>
<p>To explore the possibility that allergies increase OTM and ERR, we examined the effects of allergen sensitization on ERR and OTM using OVA-sensitized BN rats. Furthermore, we attempted to prevent ERR progression during OTM by aspirin administration, since aspirin has been reported to improve bone mineral density in human epidemiological studies (<xref ref-type="bibr" rid="bibr2-0022034513488787">Bauer <italic>et al</italic>., 1996</xref>; <xref ref-type="bibr" rid="bibr6-0022034513488787">Carbone <italic>et al</italic>., 2003</xref>).</p>
</sec>
<sec id="section2-0022034513488787" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<sec id="section3-0022034513488787">
<title>Rats</title>
<p>The experimental protocols were approved by the Animal Care and Use Committee of Kyushu University. Six-week-old male BN rats (Kyudo, Tosu, Japan) weighing 110 to 140 g were fed a powdered diet (CE-2; Clea Japan, Tokyo, Japan) and given water <italic>ad libitum</italic>.</p>
</sec>
<sec id="section4-0022034513488787">
<title>Allergen Sensitization</title>
<p>The rats were sensitized by a subcutaneous injection of saline (1 mL) containing 1 mg of OVA (grade V; Sigma-Aldrich, St. Louis, MO, USA) and 200 mg of aluminum hydroxide. A <italic>Bordetella pertussis</italic> vaccine containing 1×10<sup>10</sup> heat-killed bacilli (Wako, Osaka, Japan) was given intraperitoneally as an adjuvant, and OVA was injected after 7 days. ELISAs were used to detect total serum IgE (Shibayagi, Gunma, Japan) and OVA-specific IgE (Cusabio, Newark, DE, USA) in the OVA-alone and control groups (n = 7 <italic>per</italic> group).</p>
</sec>
<sec id="section5-0022034513488787">
<title>OTM and Aspirin Administration</title>
<p>At 7 days after the second sensitization, an Ni-Ti closed-coil spring at a force of 0.1 N (Sentalloy<sup>®</sup>, Ultra Light; Tomy International Inc., Tokyo, Japan) was inserted between the upper right first molar (M1) and the incisors (<xref ref-type="fig" rid="fig1-0022034513488787">Figs. 1A</xref>, <xref ref-type="fig" rid="fig1-0022034513488787">1B</xref>).</p>
<fig id="fig1-0022034513488787" position="float">
<label>Figure 1.</label>
<caption>
<p>Experimental design, changes in serum IgE, histology of alveolar bone, and degrees of tooth movement. <bold>(A)</bold> Scheme showing the experimental design regarding OVA sensitization, orthodontic force application, and aspirin administration. <bold>(B)</bold> Photomicrograph and scheme of rat maxillae with the orthodontic appliance. The force level of the closed-coil spring after activation is approximately 0.1 N. M1, first molar; M2, second molar; M3, third molar. <bold>(C)</bold> The total and OVA-specific IgE levels in serum are greatly elevated after the first OVA sensitization, and further elevated after the second OVA sensitization. The arrowheads indicate the times of the 2 OVA sensitizations. The arrows indicate the start of the orthodontic force application. All data are expressed as means ± SD. *<italic>p</italic> &lt; .05 by Student’s <italic>t</italic> test (n = 7 animals <italic>per</italic> group). <bold>(D)</bold> Granulocytes including eosinophils are increased in OVA-sensitized alveolar bone marrow compared with control alveolar bone marrow. The sections are stained with Giemsa. AB, alveolar bone. <bold>(E)</bold> Micro-CT photograph showing the maxilla from a rat in the OVA with OTM group. The arrows indicate the dissociation of tooth movement. <bold>(F)</bold> The degree of tooth movement is significantly greater in OVA-sensitized animals than in non-sensitized animals after tooth movement. Aspirin treatment reverses the increase in OVA-sensitized animals. All data are expressed as means ± SD. *<italic>p</italic> &lt; .05 by one-way ANOVA with Tukey’s multiple-comparison test (n = 7 animals <italic>per</italic> group).</p>
</caption>
<graphic xlink:href="10.1177_0022034513488787-fig1.tif"/>
</fig>
<p>Aspirin dissolved in feed water (250 μg/kg/day) was administered to OVA-sensitized rats at the time of orthodontic force application. For ELISA and RT-PCR analyses, aspirin was administered from 24 hrs before OTM.</p>
<p>The animals were divided into 5 groups: control group (no OVA or OTM); OVA-alone group (no OTM); OTM-alone group (no OVA); ‘OVA with OTM’ group; and ‘aspirin administration to OVA with OTM’ group. We used separate animals for the different analyses.</p>
</sec>
<sec id="section6-0022034513488787">
<title>Histology</title>
<p>After 7 and 14 days of OTM, the animals (n = 7 <italic>per</italic> group) were perfused transcardially with 200 mL of heparinized phosphate-buffered saline, pH 7.4, followed by 4% paraformaldehyde containing 0.2% picric acid in 0.1 M phosphate buffer. The right halves of maxillae decalcified in 10% EDTA were cut into 8-μm-thick parasagittal sections, and every fifth section was collected. The sections showing the greatest length of the distopalatal root together with the 5 adjacent sections on either side (total of 11 sections <italic>per</italic> animal) were stained for tartrate- resistant acid phosphatase (TRAP) (Sigma-Aldrich) or Giemsa (Merck, Darmstadt, Germany). All sections were observed under a digital microscope with MZ-II Analyzer software (BZ-9000; Keyence, Osaka, Japan).</p>
<p>After investigation of all 5 roots of M1 with surrounding structures, we found that ERR was conspicuous in the distopalatal root. We measured the area of ERR as well as the numbers of odontoclasts and osteoclasts within a defined area (Appendix Fig. 1) according to the method of <xref ref-type="bibr" rid="bibr20-0022034513488787">Mavragani <italic>et al</italic>. (2005)</xref>. The resorption area (eroded surface <italic>per</italic> bone surface; ES/BS) and adjacent osteoclasts (osteoclast number <italic>per</italic> bone surface; N.Oc/BS) were also measured in the adjacent alveolar bone. We counted TRAP-positive cells in resorption lacunae facing the tooth roots as odontoclasts, and other TRAP-positive cells (containing more than 2 nuclei) as osteoclasts.</p>
</sec>
<sec id="section7-0022034513488787">
<title>Cytokines and Leukotriene</title>
<p>The periodontal tissues, including the bone, surrounding M1 of the right maxillae after 24 hrs of OTM (n = 7 <italic>per</italic> group) were immediately frozen in liquid nitrogen and homogenized in Tris-HCl buffer, pH 7.4, containing protease inhibitors. After centrifugation, the supernatants were collected and stored at −80°C. TNF-α, IL-1β, and IL-6 were evaluated with a TNF-α ELISA Kit (Shibayagi), an IL-1β ELISA Kit, and an IL-6 ELISA Kit (BioSource, Camarillo, CA, USA), respectively, according to the manufacturers’ protocols.</p>
<p>Lipid was extracted in 100% methanol at −30°C overnight, and the level was evaluated with an EIA Kit (Cayman Chemical, Ann Arbor, MI, USA).</p>
</sec>
<sec id="section8-0022034513488787">
<title>RT-PCR</title>
<p>The periodontal tissues around M1 after 24 hrs of OTM were rapidly frozen in liquid nitrogen and homogenized (n = 4 <italic>per</italic> group). After mRNA isolation, quantitative real-time PCR or conventional RT-PCR was performed with gene-specific primer sets (Appendix Table), as described previously (<xref ref-type="bibr" rid="bibr27-0022034513488787">Wang <italic>et al</italic>., 2011</xref>). Amplification for real-time PCR was performed with a Rotor Gene 3000 (QIAGEN K.K., Tokyo, Japan). All samples were normalized by the expression of glyceraldehyde-3-phosphate dehydrogenase or 18S ribosomal RNA.</p>
</sec>
<sec id="section9-0022034513488787">
<title>Micro-CT</title>
<p>Micro-CT images were acquired at 9-µm resolution with a SkyScan 1076 (SkyScan, Antwerp, Belgium) used to assess the degree of OTM. At day 14 (10 wks of age), the hemi-maxillae were excised (n = 6 <italic>per</italic> group). The hemi-maxilla samples were directed parallel to the occlusal plane and scanned for 2.70 mm. The distance from the distal surface of M1 to the mesial surface of the second molar (M2) was measured with DataViewer software (ver. 1.4.3; SkyScan).</p>
</sec>
<sec id="section10-0022034513488787">
<title>Statistical Analysis</title>
<p>The serum IgE levels were compared by Student’s <italic>t</italic> test. The means of multiple groups were compared by one-way analysis of variance (ANOVA). Other values were compared by ANOVA followed by Tukey’s multiple-comparison test. Values of <italic>p</italic> &lt; .05 were considered to indicate statistical significance.</p>
</sec>
</sec>
<sec id="section11-0022034513488787" sec-type="results">
<title>Results</title>
<sec id="section12-0022034513488787">
<title>Systemic and Local Changes with OVA Sensitization</title>
<p>The total serum IgE and OVA-specific IgE levels were greatly elevated after the first OVA sensitization, and further elevated after the second sensitization (<xref ref-type="fig" rid="fig1-0022034513488787">Fig. 1C</xref>). Interestingly, the numbers of granulocytes including eosinophils were increased in the alveolar bone marrow at 7 days after the second OVA sensitization compared with those in non-sensitized control alveolar bone marrow (<xref ref-type="fig" rid="fig1-0022034513488787">Fig. 1D</xref>). Acute lung inflammation was confirmed by intranasal OVA challenge (Appendix Fig. 2).</p>
<p>To explore whether allergen sensitization had specific effects on only the alveolar bone with OTM or systemic effects on the long bones as well, we examined the proximal metaphyseal region of the tibia using micro-CT. There were no significant differences in the bone structural parameters between the groups (Appendix Fig. 3).</p>
<p>The body weights showed no significant differences among the groups (Appendix Fig. 4).</p>
</sec>
<sec id="section13-0022034513488787">
<title>OTM and Root and Alveolar Bone Resorption</title>
<p>At day 14, the degree of OTM was significantly larger in the ‘OVA with OTM’ group than in the OTM-alone group (<xref ref-type="fig" rid="fig1-0022034513488787">Fig. 1E</xref>). Without orthodontic force, no osteoclasts and/or odontoclasts were observed on the medial surface of the alveolar bone in any of the groups (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2A</xref>–<xref ref-type="fig" rid="fig2-0022034513488787">2E</xref>). Marked ERR was observed on the pressured side in the OTM-alone and ‘OVA with OTM’ groups (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034513488787">2D</xref>). The ‘OVA with OTM’ group exhibited broad and deep TRAP-stained areas, with resorption lacunae on the root and surrounding bone on days 7 and 14 (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2D</xref>, <xref ref-type="fig" rid="fig2-0022034513488787">2F</xref>). In addition, the numbers of odontoclasts and osteoclasts were significantly greater in the ‘OVA with OTM’ group than in the OTM-alone group (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2G</xref>, <xref ref-type="fig" rid="fig2-0022034513488787">2H</xref>). The number of osteoclasts peaked on day 7 in the ‘OVA with OTM’ group, and then decreased by day 14. While the area of ERR increased from day 7 to day 14, the number of odontoclasts was maintained during this period (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2F</xref>, <xref ref-type="fig" rid="fig2-0022034513488787">2H</xref>). The alveolar bone resorption and osteoclast numbers were significantly greater in the ‘OVA with OTM’ group than in the OTM-alone group on days 7 and 14 (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2I</xref>, <xref ref-type="fig" rid="fig2-0022034513488787">2J</xref>).</p>
<fig id="fig2-0022034513488787" position="float">
<label>Figure 2.</label>
<caption>
<p>Increased numbers of osteoclasts/odontoclasts and amounts of root/bone resorption on the pressured side after tooth movement in OVA-sensitized animals, and inhibition of these increases by aspirin administration. Histologic sections of periodontal tissues around the distopalatal root of the first molar stained for TRAP after 7 and 14 days of tooth movement <bold>(A–E)</bold> and quantitative analyses <bold>(F–J).</bold> The upper panels show low-magnification images and the lower panels show high-magnification images of the boxed areas in the upper panels. <bold>(A)</bold> Control group (without treatment). <bold>(B)</bold> OVA-alone group. <bold>(C)</bold> OTM-alone group. <bold>(D)</bold> ‘OVA with OTM’ group. <bold>(E)</bold> ‘Aspirin administration to OVA with OTM’ group. <bold>(F)</bold> Area of root resorption (×10<sup>3</sup> μm<sup>2</sup>). <bold>(G)</bold> Number of osteoclasts. <bold>(H)</bold> Number of odontoclasts. <bold>(I)</bold> Eroded surface <italic>per</italic> alveolar bone surface (ES/BS). <bold>(J)</bold> Number of osteoclasts <italic>per</italic> alveolar bone surface (N.Oc/BS). The white arrows indicate the orthodontic force direction. The black arrows indicate TRAP-positive osteoclasts. The arrowheads indicate TRAP-positive odontoclasts. The sections are counterstained with toluidine blue. AB, alveolar bone; D, dentin; PL, periodontal ligament. All data are expressed as means ± SD. *<italic>p</italic> &lt; .05 by one-way ANOVA with Tukey’s multiple-comparison test (n = 7 animals <italic>per</italic> group).</p>
</caption>
<graphic xlink:href="10.1177_0022034513488787-fig2.tif"/>
</fig>
</sec>
<sec id="section14-0022034513488787">
<title>Cytokines</title>
<p>To identify the possible mechanism for the elevated ERR, we examined the levels of cytokines in the periodontal tissues surrounding M1 after 24 hrs of OTM. The IL-4 level was significantly higher in the OVA-alone and ‘OVA with OTM’ groups than in the control group (<xref ref-type="fig" rid="fig3-0022034513488787">Fig. 3A</xref>). The levels of RANKL, TNF-α, and IL-1β were significantly higher in the ‘OVA with OTM’ group than in the other groups (<xref ref-type="fig" rid="fig3-0022034513488787">Figs. 3B</xref>–<xref ref-type="fig" rid="fig3-0022034513488787">3D</xref>), while the difference in IL-6 was not significant (<xref ref-type="fig" rid="fig3-0022034513488787">Fig. 3E</xref>). Although there were no significant differences between the OVA-alone and control groups, the OTM-alone group showed tendencies toward higher levels of TNF-α and IL-1β (<xref ref-type="fig" rid="fig3-0022034513488787">Figs. 3C</xref>, <xref ref-type="fig" rid="fig3-0022034513488787">3D</xref>).</p>
<fig id="fig3-0022034513488787" position="float">
<label>Figure 3.</label>
<caption>
<p>Elevated expressions of cytokines in periodontal tissues after 24 hrs of tooth movement in OVA-sensitized animals, and suppression of these elevations by aspirin administration. <bold>(A)</bold> IL-4. <bold>(B)</bold> RANKL. <bold>(C)</bold> TNF-α. <bold>(D)</bold> IL-1β. <bold>(E)</bold> IL-6. All data are expressed as means ± SD. *<italic>p</italic> &lt; .05 by one-way ANOVA with Tukey’s multiple-comparison test (n = 7 animals <italic>per</italic> group).</p>
</caption>
<graphic xlink:href="10.1177_0022034513488787-fig3.tif"/>
</fig>
</sec>
<sec id="section15-0022034513488787">
<title>LTB<sub>4</sub> and Related Factors</title>
<p>The LTB<sub>4</sub> level and mRNA levels of the synthases 5-LOX and LTA<sub>4</sub> hydrolase (LTA<sub>4</sub>h) were significantly higher in the ‘OVA with OTM’ group than in the other groups after 24 hrs of OTM (<xref ref-type="fig" rid="fig4-0022034513488787">Figs. 4A</xref>–<xref ref-type="fig" rid="fig2-0022034513488787">4C</xref>, <xref ref-type="fig" rid="fig4-0022034513488787">4F</xref>). The mRNA levels of the LTB<sub>4</sub> receptors BLT1 and BLT2 were also higher in the ‘OVA with OTM’ group (<xref ref-type="fig" rid="fig4-0022034513488787">Figs. 4D</xref>–<xref ref-type="fig" rid="fig4-0022034513488787">4F</xref>).</p>
<fig id="fig4-0022034513488787" position="float">
<label>Figure 4.</label>
<caption>
<p>Augmentation of LTB<sub>4</sub> levels and mRNA levels of LTB<sub>4</sub> synthases and receptors in periodontal tissues after 24 hrs of tooth movement in OVA-sensitized animals, and inhibition of these elevations by aspirin administration. <bold>(A)</bold> Concentration of LTB<sub>4</sub> in periodontal tissues. <bold>(B–F)</bold> mRNA levels of leukotriene synthases and receptors determined by real-time <bold>(B)</bold> and conventional <bold>(C–F)</bold> RT-PCR. The mRNA levels of the leukotriene synthases 5-LOX <bold>(B)</bold> and LTA<sub>4</sub>h <bold>(C)</bold>, and BLT1 <bold>(D)</bold> and BLT2 <bold>(E)</bold> and the electrophoretograms <bold>(F)</bold> are shown. All data are expressed as means ± SD. *<italic>p</italic> &lt; .05 by one-way ANOVA with Tukey’s multiple-comparison test (n = 4 animals <italic>per</italic> group).</p>
</caption>
<graphic xlink:href="10.1177_0022034513488787-fig4.tif"/>
</fig>
</sec>
<sec id="section16-0022034513488787">
<title>Effects of Aspirin Administration</title>
<p>Aspirin treatment reversed the degree of OTM in the ‘OVA with OTM’ group to a level similar to that in the OTM-alone group on day 14 (<xref ref-type="fig" rid="fig1-0022034513488787">Fig. 1E</xref>). Histologic examinations revealed that the area of ERR and numbers of odontoclasts/osteoclasts were decreased to the levels observed in the OTM-alone group (<xref ref-type="fig" rid="fig2-0022034513488787">Figs. 2E</xref>–<xref ref-type="fig" rid="fig2-0022034513488787">2J</xref>). The levels of IL-4 and RANKL mRNAs, and TNF-α, IL-1β, and IL-6 proteins were also suppressed to the levels detected in the OTM-alone group (<xref ref-type="fig" rid="fig3-0022034513488787">Fig. 3</xref>). Furthermore, the amounts of LTB<sub>4</sub>, BLT1, BLT2, 5-LOX, and LTA<sub>4</sub>h were also suppressed by aspirin treatment (<xref ref-type="fig" rid="fig4-0022034513488787">Fig. 4</xref>).</p>
</sec>
</sec>
<sec id="section17-0022034513488787" sec-type="discussion">
<title>Discussion</title>
<p>The main findings of the present study are that the amounts of OTM, alveolar bone resorption, and ERR appear to be associated with systemic allergen sensitization. The increased numbers of odontoclasts/osteoclasts on the pressured side during OTM in OVA-sensitized rats, suggesting odontoclastogenesis/osteoclastogenesis under the condition of orthodontic force, were stimulated by systemic allergen sensitization. Since we observed these changes in maxillae after OVA sensitization (under high serum IgE conditions) without further OVA challenge to the skin or nose, the allergic background may be associated with susceptibility to ERR. These findings may support the idea that allergic diseases affect OTM, which was raised by our previous epidemiologic observations showing increased rates of ERR in patients with allergic diseases (<xref ref-type="bibr" rid="bibr23-0022034513488787">Nishioka <italic>et al</italic>., 2006</xref>).</p>
<p>We found markedly elevated serum IgE and OVA-specific IgE levels and, at the same time, observed increased infiltration of inflammatory granulocytes and IL-4 mRNA levels in the periodontal tissue. These findings suggest that OVA sensitization stimulates IL-4 production, consistent with a previous report (<xref ref-type="bibr" rid="bibr25-0022034513488787">Renzi <italic>et al</italic>., 1996</xref>). Furthermore, higher expressions of TNF-α and IL-1β, well-known pro-inflammatory cytokines, were detected in the periodontal tissues of the ‘OTM with OVA’ group. Recently, <xref ref-type="bibr" rid="bibr24-0022034513488787">Polzer <italic>et al</italic>. (2011)</xref> reported that TNF-α-transgenic IL-1β-deleted mice were protected against bone loss, suggesting that IL-1β contributes to TNF-α-mediated inflammatory osteopenia. The elevated levels of TNF-α and IL-1β, together with RANKL as an essential cytokine for osteoclastogenesis, suggest increased rates and magnitudes of ERR and OTM for the differentiation of odontoclasts/osteoclasts. IL-4 is known to suppress TNF-α and RANKL-mediated osteoclast formation <italic>in vitro</italic> (<xref ref-type="bibr" rid="bibr17-0022034513488787">Kong <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="bibr16-0022034513488787">Kitaura <italic>et al</italic>., 2003</xref>) and <italic>in vivo</italic> (<xref ref-type="bibr" rid="bibr9-0022034513488787">Fujii <italic>et al</italic>., 2012</xref>), while mice overexpressing IL-4 develop systemic bone loss (<xref ref-type="bibr" rid="bibr18-0022034513488787">Lewis <italic>et al</italic>., 1993</xref>). In the periodontal tissues of allergen-sensitized animals, clarification of the cytokines that cause the exacerbation of tooth or bone resorption requires further studies.</p>
<p>Leukotrienes have been implicated in bone remodeling in several reports. <xref ref-type="bibr" rid="bibr10-0022034513488787">Garcia <italic>et al</italic>. (1996)</xref> showed that LTB<sub>4</sub> stimulated osteoclastic bone resorption, and <xref ref-type="bibr" rid="bibr13-0022034513488787">Hikiji <italic>et al</italic>. (2009)</xref> demonstrated that bone resorption was attenuated in ovariectomized BLT1-knockout mice. We observed higher levels of LTB<sub>4</sub> together with increased expressions of the receptors BLT1 and BLT2, as well as 5-LOX and LTA<sub>4</sub>h, biosynthetic enzymes for leukotrienes, suggesting enhanced production of LTB<sub>4</sub> in the tissues during OTM with allergic inflammation. Based on these findings, the elevated expressions of LTB<sub>4</sub> and its receptors together with the pro-inflammatory cytokines TNF-α and IL-1β may augment the ERR and OTM through RANKL-mediated osteoclastogenesis. It can be considered that the reciprocal induction of the leukotriene pathway and pro-inflammatory cytokines is involved in the mechanisms of ERR and OTM.</p>
<p>Elderly men and women taking aspirin were reported to show higher bone mineral density than non-takers (<xref ref-type="bibr" rid="bibr6-0022034513488787">Carbone <italic>et al</italic>., 2003</xref>). <xref ref-type="bibr" rid="bibr28-0022034513488787">Yamaza <italic>et al</italic>. (2008)</xref> showed that low-dose aspirin inhibited ovariectomy-induced osteoporosis by inhibiting T-cell activation in mice. Administration of aspirin at much lower doses than for general use as a painkiller was able to reverse the increases in ERR, degrees of OTM, and the levels of leukotriene signaling pathway components in our allergen-sensitized model. These findings raise the possibility that low-dose aspirin administration inhibits osteoclastogenesis under inflammatory conditions through the production of anti-inflammatory lipid mediator resolvins (<xref ref-type="bibr" rid="bibr4-0022034513488787">Bento <italic>et al</italic>., 2011</xref>). In our limited experimental period, we did not find that allergy affected the bone structural parameters of the tibia. However, repeated sensitization with allergens over a longer period suggested effects on bone metabolism (unpublished observations). Thus, the increased degree of OTM could be caused by alterations in the structural properties of alveolar bone as well as the enhanced osteoclastogenesis. For further understanding of the complexity and diversity of molecules associated with the regulation of root and alveolar bone resorption with allergic inflammation, both systemic and loco-regional experiments are needed.</p>
<p>In conclusion, we have proposed a model for studying the effects of allergen-induced inflammation and/or mechanical stress on ERR during OTM. This process was affected by pro-inflammatory cytokines, together with lipid mediators. Furthermore, our findings suggest that pro-inflammatory cytokines and leukotrienes, together with low-dose aspirin, may represent pharmacological targets for ERR during orthodontic treatment with allergic conditions.</p>
</sec>
</body>
<back>
<ack>
<p>We thank Dr. I. Takahashi for valuable advice. We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University.</p>
</ack>
<fn-group>
<fn fn-type="supported-by">
<p>This study was supported by a Grant-in-Aid for Scientific Research (C) (to H.I.) and by a Grant-in-Aid for Young Scientists (B) (to N.M.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.</p></fn>
<fn fn-type="conflict">
<p>The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.</p></fn>
<fn fn-type="supplementary-material">
<p>A supplemental appendix to this article is published electronically only at <ext-link ext-link-type="uri" xlink:href="http://jdr.sagepub.com/supplemental">http://jdr.sagepub.com/supplemental</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Azuma</surname><given-names>Y</given-names></name>
<name><surname>Kaji</surname><given-names>K</given-names></name>
<name><surname>Katogi</surname><given-names>R</given-names></name>
<name><surname>Takeshita</surname><given-names>S</given-names></name>
<name><surname>Kudo</surname><given-names>A</given-names></name>
</person-group> (<year>2000</year>). <article-title>Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts</article-title>. <source>J Biol Chem</source> <volume>275</volume>:<fpage>4858</fpage>-<lpage>4864</lpage>.</citation>
</ref>
<ref id="bibr2-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauer</surname><given-names>DC</given-names></name>
<name><surname>Orwoll</surname><given-names>ES</given-names></name>
<name><surname>Fox</surname><given-names>KM</given-names></name>
<name><surname>Vogt</surname><given-names>TM</given-names></name>
<name><surname>Lane</surname><given-names>NE</given-names></name>
<name><surname>Hochberg</surname><given-names>MC</given-names></name><etal/>
</person-group>. (<year>1996</year>). <article-title>Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk</article-title>. <source>J Bone Miner Res</source> <volume>11</volume>:<fpage>29</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr3-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bellofiore</surname><given-names>S</given-names></name>
<name><surname>Martin</surname><given-names>JG</given-names></name>
</person-group> (<year>1988</year>). <article-title>Antigen challenge of sensitized rats increases airway responsiveness to methacholine</article-title>. <source>J Appl Physiol</source> <volume>65</volume>:<fpage>1642</fpage>-<lpage>1646</lpage>.</citation>
</ref>
<ref id="bibr4-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bento</surname><given-names>AF</given-names></name>
<name><surname>Claudino</surname><given-names>RF</given-names></name>
<name><surname>Dutra</surname><given-names>RC</given-names></name>
<name><surname>Marcon</surname><given-names>R</given-names></name>
<name><surname>Calixto</surname><given-names>JB</given-names></name>
</person-group> (<year>2011</year>). <article-title>Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice</article-title>. <source>J Immunol</source> <volume>187</volume>:<fpage>1957</fpage>-<lpage>1969</lpage>.</citation>
</ref>
<ref id="bibr5-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bertolini</surname><given-names>DR</given-names></name>
<name><surname>Nedwin</surname><given-names>GE</given-names></name>
<name><surname>Bringman</surname><given-names>TS</given-names></name>
<name><surname>Smith</surname><given-names>DD</given-names></name>
<name><surname>Mundy</surname><given-names>GR</given-names></name>
</person-group> (<year>1986</year>). <article-title>Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors</article-title>. <source>Nature</source> <volume>319</volume>:<fpage>516</fpage>-<lpage>518</lpage>.</citation>
</ref>
<ref id="bibr6-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carbone</surname><given-names>LD</given-names></name>
<name><surname>Tylavsky</surname><given-names>FA</given-names></name>
<name><surname>Cauley</surname><given-names>JA</given-names></name>
<name><surname>Harris</surname><given-names>TB</given-names></name>
<name><surname>Lang</surname><given-names>TF</given-names></name>
<name><surname>Bauer</surname><given-names>DC</given-names></name><etal/>
</person-group>. (<year>2003</year>). <article-title>Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity</article-title>. <source>J Bone Miner Res</source> <volume>18</volume>:<fpage>1795</fpage>-<lpage>1802</lpage>.</citation>
</ref>
<ref id="bibr7-0022034513488787">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Davidovitch</surname><given-names>Z</given-names></name>
<name><surname>Lee</surname><given-names>XJ</given-names></name>
<name><surname>Counts</surname><given-names>AL</given-names></name>
<name><surname>Park</surname><given-names>YG</given-names></name>
</person-group> (<year>2000</year>). <article-title>The immune system possibly modulates orthodontic root resorption. In: Biological mechanisms of tooth movement and craniofacial adaptation</article-title>. <person-group person-group-type="editor">
<name><surname>Davidovitch</surname><given-names>Z</given-names></name>
<name><surname>Mah</surname><given-names>J</given-names></name>
</person-group>, editors. <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>Harvard Society for the Advancement of Orthodontics</publisher-name>, pp. <fpage>207</fpage>-<lpage>217</lpage>.</citation>
</ref>
<ref id="bibr8-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Emingil</surname><given-names>G</given-names></name>
<name><surname>Cinarcik</surname><given-names>S</given-names></name>
<name><surname>Baylas</surname><given-names>H</given-names></name>
<name><surname>Coker</surname><given-names>I</given-names></name>
<name><surname>Huseyinov</surname><given-names>A</given-names></name>
</person-group> (<year>2001</year>). <article-title>Levels of leukotriene B4 in gingival crevicular fluid and gingival tissue in specific periodontal diseases</article-title>. <source>J Periodontol</source> <volume>72</volume>:<fpage>1025</fpage>-<lpage>1031</lpage>.</citation>
</ref>
<ref id="bibr9-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujii</surname><given-names>T</given-names></name>
<name><surname>Kitaura</surname><given-names>H</given-names></name>
<name><surname>Kimura</surname><given-names>K</given-names></name>
<name><surname>Hakami</surname><given-names>ZW</given-names></name>
<name><surname>Takano-Yamamoto</surname><given-names>T</given-names></name>
</person-group> (<year>2012</year>). <article-title>IL-4 inhibits TN F-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo</article-title>. <source>Bone</source> <volume>51</volume>:<fpage>771</fpage>-<lpage>780</lpage>.</citation>
</ref>
<ref id="bibr10-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garcia</surname><given-names>C</given-names></name>
<name><surname>Boyce</surname><given-names>BF</given-names></name>
<name><surname>Gilles</surname><given-names>J</given-names></name>
<name><surname>Dallas</surname><given-names>M</given-names></name>
<name><surname>Qiao</surname><given-names>M</given-names></name>
<name><surname>Mundy</surname><given-names>GR</given-names></name><etal/>
</person-group>. (<year>1996</year>). <article-title>Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo</article-title>. <source>J Bone Miner Res</source> <volume>11</volume>:<fpage>1619</fpage>-<lpage>1627</lpage>.</citation>
</ref>
<ref id="bibr11-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hallstrand</surname><given-names>TS</given-names></name>
<name><surname>Henderson</surname><given-names>WR</given-names><suffix>Jr</suffix></name>
</person-group> (<year>2010</year>). <article-title>An update on the role of leukotrienes in asthma</article-title>. <source>Curr Opin Allergy Clin Immunol</source> <volume>10</volume>:<fpage>60</fpage>-<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr12-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heath</surname><given-names>JK</given-names></name>
<name><surname>Saklatvala</surname><given-names>J</given-names></name>
<name><surname>Meikle</surname><given-names>MC</given-names></name>
<name><surname>Atkinson</surname><given-names>SJ</given-names></name>
<name><surname>Reynolds</surname><given-names>JJ</given-names></name>
</person-group> (<year>1985</year>). <article-title>Pig interleukin 1 (catabolin) is a potent stimulator of bone resorption in vitro</article-title>. <source>Calcif Tissue Int</source> <volume>7</volume>:<fpage>95</fpage>-<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr13-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hikiji</surname><given-names>H</given-names></name>
<name><surname>Ishii</surname><given-names>S</given-names></name>
<name><surname>Yokomizo</surname><given-names>T</given-names></name>
<name><surname>Takato</surname><given-names>T</given-names></name>
<name><surname>Shimizu</surname><given-names>T</given-names></name>
</person-group> (<year>2009</year>). <article-title>A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>106</volume>:<fpage>21294</fpage>-<lpage>21299</lpage>.</citation>
</ref>
<ref id="bibr14-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Imada</surname><given-names>T</given-names></name>
<name><surname>Komorita</surname><given-names>N</given-names></name>
<name><surname>Kobayashi</surname><given-names>F</given-names></name>
<name><surname>Naito</surname><given-names>K</given-names></name>
<name><surname>Yoshikawa</surname><given-names>T</given-names></name>
<name><surname>Miyazaki</surname><given-names>M</given-names></name><etal/>
</person-group>. (<year>2002</year>). <article-title>Therapeutic potential of a specific chymase inhibitor in atopic dermatitis</article-title>. <source>Jpn J Pharmacol</source> <volume>90</volume>:<fpage>214</fpage>-<lpage>217</lpage>.</citation>
</ref>
<ref id="bibr15-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kanzaki</surname><given-names>H</given-names></name>
<name><surname>Chiba</surname><given-names>M</given-names></name>
<name><surname>Shimizu</surname><given-names>Y</given-names></name>
<name><surname>Mitani</surname><given-names>H</given-names></name>
</person-group> (<year>2002</year>). <article-title>Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis</article-title>. <source>J Bone Miner Res</source> <volume>17</volume>:<fpage>210</fpage>-<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr16-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kitaura</surname><given-names>H</given-names></name>
<name><surname>Nagata</surname><given-names>N</given-names></name>
<name><surname>Fujimura</surname><given-names>Y</given-names></name>
<name><surname>Hotokezaka</surname><given-names>H</given-names></name>
<name><surname>Tatamiya</surname><given-names>M</given-names></name>
<name><surname>Nakao</surname><given-names>N</given-names></name><etal/>
</person-group>. (<year>2003</year>). <article-title>Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages</article-title>. <source>Immunol Lett</source> <volume>88</volume>:<fpage>193</fpage>-<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr17-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kong</surname><given-names>YY</given-names></name>
<name><surname>Yoshida</surname><given-names>H</given-names></name>
<name><surname>Sarosi</surname><given-names>I</given-names></name>
<name><surname>Tan</surname><given-names>HL</given-names></name>
<name><surname>Timms</surname><given-names>E</given-names></name>
<name><surname>Capparelli</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>1999</year>). <article-title>OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis</article-title>. <source>Nature</source> <volume>397</volume>:<fpage>315</fpage>-<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr18-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>DB</given-names></name>
<name><surname>Liggitt</surname><given-names>HD</given-names></name>
<name><surname>Effmann</surname><given-names>EL</given-names></name>
<name><surname>Motley</surname><given-names>ST</given-names></name>
<name><surname>Teitelbaum</surname><given-names>SL</given-names></name>
<name><surname>Jepsen</surname><given-names>KJ</given-names></name><etal/>
</person-group>. (<year>1993</year>). <article-title>Osteoporosis induced in mice by overproduction of interleukin 4</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>90</volume>:<fpage>11618</fpage>-<lpage>11622</lpage>.</citation>
</ref>
<ref id="bibr19-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lowney</surname><given-names>JJ</given-names></name>
<name><surname>Norton</surname><given-names>LA</given-names></name>
<name><surname>Shafer</surname><given-names>DM</given-names></name>
<name><surname>Rossomando</surname><given-names>EF</given-names></name>
</person-group> (<year>1995</year>). <article-title>Orthodontic forces increase tumor necrosis factor alpha in the human gingival sulcus</article-title>. <source>Am J Orthod Dentofacial Orthop</source> <volume>108</volume>:<fpage>519</fpage>-<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr20-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mavragani</surname><given-names>M</given-names></name>
<name><surname>Brudvik</surname><given-names>P</given-names></name>
<name><surname>Selvig</surname><given-names>KA</given-names></name>
</person-group> (<year>2005</year>). <article-title>Orthodontically induced root and alveolar bone resorption: inhibitory effect of systemic doxycycline administration in rats</article-title>. <source>Eur J Orthod</source> <volume>27</volume>:<fpage>215</fpage>-<lpage>225</lpage>.</citation>
</ref>
<ref id="bibr21-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McNab</surname><given-names>S</given-names></name>
<name><surname>Battistutta</surname><given-names>D</given-names></name>
<name><surname>Taverne</surname><given-names>A</given-names></name>
<name><surname>Symons</surname><given-names>AL</given-names></name>
</person-group> (<year>1999</year>). <article-title>External apical root resorption of posterior teeth in asthmatics after orthodontic treatment</article-title>. <source>Am J Orthod Dentofacial Orthop</source> <volume>116</volume>:<fpage>545</fpage>-<lpage>551</lpage>.</citation>
</ref>
<ref id="bibr22-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>RC</given-names></name>
<name><surname>Gijon</surname><given-names>MA</given-names></name>
</person-group> (<year>2007</year>). <article-title>Biosynthesis and metabolism of leukotrienes</article-title>. <source>Biochem J</source> <volume>405</volume>:<fpage>379</fpage>-<lpage>395</lpage>.</citation>
</ref>
<ref id="bibr23-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nishioka</surname><given-names>M</given-names></name>
<name><surname>Ioi</surname><given-names>H</given-names></name>
<name><surname>Nakata</surname><given-names>S</given-names></name>
<name><surname>Nakasima</surname><given-names>A</given-names></name>
<name><surname>Counts</surname><given-names>A</given-names></name>
</person-group> (<year>2006</year>). <article-title>Root resorption and immune system factors in the Japanese</article-title>. <source>Angle Orthod</source> <volume>76</volume>:<fpage>103</fpage>-<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr24-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Polzer</surname><given-names>K</given-names></name>
<name><surname>Neubert</surname><given-names>K</given-names></name>
<name><surname>Meister</surname><given-names>S</given-names></name>
<name><surname>Frey</surname><given-names>B</given-names></name>
<name><surname>Baum</surname><given-names>W</given-names></name>
<name><surname>Distler</surname><given-names>JH</given-names></name><etal/>
</person-group>. (<year>2011</year>). <article-title>Proteasome inhibition aggravates TNF-mediated bone resorption</article-title>. <source>Arthritis Rheum</source> <volume>63</volume>:<fpage>670</fpage>-<lpage>680</lpage>.</citation>
</ref>
<ref id="bibr25-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Renzi</surname><given-names>PM</given-names></name>
<name><surname>al Assaad</surname><given-names>AS</given-names></name>
<name><surname>Yang</surname><given-names>J</given-names></name>
<name><surname>Yasruel</surname><given-names>Z</given-names></name>
<name><surname>Hamid</surname><given-names>Q</given-names></name>
</person-group> (<year>1996</year>). <article-title>Cytokine expression in the presence or absence of late airway responses after antigen challenge of sensitized rats</article-title>. <source>Am J Respir Cell Mol Biol</source> <volume>15</volume>:<fpage>367</fpage>-<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr26-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suda</surname><given-names>T</given-names></name>
<name><surname>Takahashi</surname><given-names>N</given-names></name>
<name><surname>Udagawa</surname><given-names>N</given-names></name>
<name><surname>Jimi</surname><given-names>E</given-names></name>
<name><surname>Gillespie</surname><given-names>MT</given-names></name>
<name><surname>Martin</surname><given-names>TJ</given-names></name>
</person-group> (<year>1999</year>). <article-title>Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families</article-title>. <source>Endocr Rev</source> <volume>20</volume>:<fpage>345</fpage>-<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr27-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B</given-names></name>
<name><surname>Danjo</surname><given-names>A</given-names></name>
<name><surname>Kajiya</surname><given-names>H</given-names></name>
<name><surname>Okabe</surname><given-names>K</given-names></name>
<name><surname>Kido</surname><given-names>MA</given-names></name>
</person-group> (<year>2011</year>). <article-title>Oral epithelial cells are activated <italic>via</italic> TRP channels</article-title>. <source>J Dent Res</source> <volume>90</volume>:<fpage>163</fpage>-<lpage>167</lpage>.</citation>
</ref>
<ref id="bibr28-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamaza</surname><given-names>T</given-names></name>
<name><surname>Miura</surname><given-names>Y</given-names></name>
<name><surname>Bi</surname><given-names>Y</given-names></name>
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Akiyama</surname><given-names>K</given-names></name>
<name><surname>Sonoyama</surname><given-names>W</given-names></name><etal/>
</person-group>. (<year>2008</year>). <article-title>Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents</article-title>. <source>PLoS One</source> <volume>3</volume>:<fpage>e2615</fpage>.</citation>
</ref>
<ref id="bibr29-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yokomizo</surname><given-names>T</given-names></name>
<name><surname>Izumi</surname><given-names>T</given-names></name>
<name><surname>Chang</surname><given-names>K</given-names></name>
<name><surname>Takuwa</surname><given-names>Y</given-names></name>
<name><surname>Shimizu</surname><given-names>T</given-names></name>
</person-group> (<year>1997</year>). <article-title>A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis</article-title>. <source>Nature</source> <volume>387</volume>:<fpage>620</fpage>-<lpage>624</lpage>.</citation>
</ref>
<ref id="bibr30-0022034513488787">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yokomizo</surname><given-names>T</given-names></name>
<name><surname>Kato</surname><given-names>K</given-names></name>
<name><surname>Terawaki</surname><given-names>K</given-names></name>
<name><surname>Izumi</surname><given-names>T</given-names></name>
<name><surname>Shimizu</surname><given-names>T</given-names></name>
</person-group> (<year>2000</year>). <article-title>A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders</article-title>. <source>J Exp Med</source> <volume>192</volume>:<fpage>421</fpage>-<lpage>432</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>